Interventional: Page 101

FDA reports RF ablation deaths

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has issued a Public Health Notification regarding reported deaths following radiofrequency (RF) ablation of lung tumors.

December 11, 2007

YMed reaches milestone with VascuTraK catheter

By AuntMinnie.com staff writers

Interventional products developer YMed said that the first U.S. clinical cases have been completed for its VascuTraK II PTA dilatation catheter.

December 10, 2007

Vertebral body pattern may indicate risk for cement-related fracture

By Shalmali Pal

In a paper in the December American Journal of Roentgenology, Dr. Noboru Tanigawa and colleagues from the department of radiology at Kansai Medical University in Osaka, Japan, hypothesized that different cement patterns in treated vertebrae have an impact on the frequency of new compression fractures. They tested this theory in 76 patients with 266 osteoporosis-related fractures who underwent vertebroplasty.

December 4, 2007

Medtronic completes PMA filing for Talent

By AuntMinnie.com staff writers

Interventional technology firm Medtronic has filed the final module of its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its Talent abdominal stent graft system.

December 2, 2007

US guidance needles away the pain of rotator cuff calcific tendinitis

By Edward Susman

CHICAGO - A 15-minute, inexpensive procedure using ultrasound guidance and local anesthesia can relieve severe, disabling shoulder pain caused by calcific tendinitis of the rotator cuff, according to physicians from Italy. In a presentation at the RSNA 2007 meeting, they described the details of procedure and reported the results from nearly 2,800 patients who received the treatment.

November 28, 2007

MRI OK for patients with newer implanted cardiac devices

By Shalmali Pal

CHIGAGO - Patients with implanted pacemakers or defibrillators no longer need to be routinely denied much-needed MR scans, according to a presentation Sunday at the 2007 RSNA meeting. Researchers from Italy found that 1.5-tesla MR was safe in their patients with the new generation of cardiac devices.

November 24, 2007